Beam Therapeutics BEAM
NASDAQ BEAM
$24.52 +0.29 (+1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Net Margin (2019 - 2026)

Updated

Beam Therapeutics (BEAM) posted Net Margin of -25036.33% for Q2 2026, down 23829.88 percentage points from -1206.45% a year earlier and down 24739.15 percentage points from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Net Margin (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Beam Therapeutics was -54.75%, up 604.75 percentage points year-over-year; for FY2025, it came in at -57.24%, up 535.88 percentage points from FY2024.

  • Annual Net Margin shows a five-year change of +816063.59 percentage points (FY2020 to FY2025).
  • In prior years, Beam Therapeutics' Net Margin was -593.13% in FY2024 (-558.04 pp), -35.09% in FY2023 (+439.45 pp), -474.54% in FY2022 (+240.37 pp) and -714.91% in FY2021 (+815405.92 pp).
  • The Q2 2026 figure stands as the lowest quarterly Net Margin since Q2 2021.
  • On a year-over-year basis, Net Margin increased in two of the last eight quarters, with an average year-over-year change of -2957.88 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q1 2022, with a gain of 3358512.48 percentage points; the weakest was Q2 2026, with a drop of 23829.88 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -297.18% (Q1 2026), 214.09% (Q4 2025) and -1162.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Beam Therapeutics 2.50 Bn 2.50 Bn - -25,036.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25,036.33%
Mar 31, 2026 -297.18%
Dec 31, 2025 214.09%
Sep 30, 2025 -1,162.38%
Jun 30, 2025 -1,206.45%
Mar 31, 2025 -1,450.20%
Dec 31, 2024 -300.51%
Sep 30, 2024 -677.47%
Jun 30, 2024 -773.45%
Mar 31, 2024 -1,331.57%
Dec 31, 2023 45.16%
Sep 30, 2023 -558.88%
Jun 30, 2023 -411.49%
Mar 31, 2023 -398.46%
Dec 31, 2022 -191.39%
Sep 30, 2022 -693.56%
Jun 30, 2022 -432.08%
Mar 31, 2022 -820.85%
Dec 31, 2021 -126.71%
Sep 30, 2021 -3,685.19%
API Access

Beam Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=BEAM&period=max&api_key=YOUR_API_KEY